You searched for Small cell lung cancer - Page 2 of 46

Finding Strength After a Small Cell Lung Cancer Diagnosis: Bob’s Story

Bethany Johnson (GO2 for Lung Cancer)2023-10-05T15:35:59-05:00October 3rd, 2023|Newsletter Articles, Small Cell Lung Cancer Spotlight, Spotlights, Stories of Hope, Your Community|

After spending over 20 years in the hospitality field, Bob Iles changed careers and joined the stock brokerage industry before retiring almost six years ago. He and his husband live in Palm Springs, CA, where he enjoys swimming in his lap pool, hiking, biking, volunteering for environmental and LGBTQ+ causes, and working with those facing cancer. My diagnosis and treatment In November 2019, I developed a concerning cough that led me to make an appointment with my doctor. After imaging [...]

0

Support for Small Cell Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2023-10-04T13:05:44-05:00October 2nd, 2023|Hot Topics, Newsletter Articles, Your Community|

GO2 for Lung Cancer’s Small Cell Lung Cancer (SCLC) program offers education, support, and connection to those affected by SCLC. People living with SCLC often have different needs than those with non-small cell lung cancer (NSCLC). Our SCLC program aims to better meet those needs by expanding our SCLC-specific resources, providing support, and building intentional communities in-person and online for authentic relationships. Our SCLC-specific programs and services include: Ways to connect with others with SCLC for support and understanding. Phone Buddy [...]

0

Living Room Show Notes: New Age of Small Cell Lung Cancer

Bradley Newton2023-09-06T15:31:30-05:00September 6th, 2023|Hot Topics, Newsletter Articles, Your Community|

Small cell lung cancer (SCLC), which represents about 15% of all lung cancer diagnoses, is an often-aggressive form of lung cancer that has historically been difficult to treat. However, the science driving new treatments for SCLC is moving faster than ever before, with more drugs in development right now than in the last 50 years combined! Dr. Jacob Sands from Dana-Farber Cancer Institute and Harvard Medical School joined GO2’s August episode of the Lung Cancer Living Room to share current SCLC [...]

3

ASCO 2023: Progress for Metastatic (Stage 4) Non-Small Cell Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2023-07-25T15:04:43-05:00July 25th, 2023|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

By Andrew Ciupek, PhD, Associate Director, Clinical Research, GO2 for Lung Cancer New research on metastatic (stage 4) non-small cell lung cancer (NSCLC) was a hot topic at the 2023 American Society of Clinical Oncology (ASCO) meeting. Data from several studies was shared, including new developments for both people living with NSCLC with driver mutations (like ALK, EGFR, and more) and those without. Targeted therapy Targeted therapies are aimed at a certain “target” in cancer cells. Their goal is to [...]

2

Lung Cancer Living Room: The New Age of Small Cell Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2023-07-19T09:34:31-05:00July 19th, 2023|Living Room|

Join our Lung Cancer Living Room discussion on "The New Age of Small Cell Lung Cancer" with Dr. Jacob Sands, MD, Physician, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School. Learn more about the Living Room and plan to join us on YouTube Live. If attending in-person, please arrive by 5 pm PT.

0

Advances in Treatment for Early Stage Non-Small Cell Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2022-10-27T09:52:39-05:00October 27th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Author: Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program For many years, the treatment options given to patients diagnosed with early stage non-small cell lung cancer (NSCLC) was limited to surgery with or without chemotherapy to improve outcomes. However, like with metastatic NSCLC, the treatment landscape for patients with early-stage NSCLC has shifted much more towards a precision medicine approach. In this article we will give an overview of the new direction in treatment options before surgery (neoadjuvant), after surgery [...]

0

Living Room Recap – Reasons to be Optimistic About Small Cell Lung Cancer (SCLC)

Bethany Johnson (GO2 for Lung Cancer)2023-09-20T12:45:02-05:00August 31st, 2022|Hot Topics, Small Cell Lung Cancer|

Small cell lung cancer (SCLC) can be a highly aggressive form of lung cancer and can be difficult to treat. It is the rarest of the major lung cancer types and represents just 15% of all diagnoses. Unfortunately, few meaningful treatment advancements or improvements in survival rates have occurred in the last few decades for this biologically complex cancer. But there is a reason to be optimistic about the future of small cell lung cancer. In August’s Living Room [...]

2

New Treatments on the Horizon for Small Cell Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2023-09-20T12:45:03-05:00June 27th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research, Small Cell Lung Cancer|

Author: Jennifer C. King, PhD, Chief Scientific Officer People diagnosed with small cell lung cancer (SCLC) have historically had limited treatment options—but researchers are working to change that. At the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, results from a few key studies were presented for the first time, offering hope for future SCLC treatment advancements. Immunotherapy for Extensive-Stage Small Cell Lung Cancer In the last few years, it has become standard to use immunotherapy, either Tecentriq (atezolizumab) [...]

0

Small Cell Lung Cancer Transformation: What Is It and How Do We Treat It?

Bethany Johnson (GO2 for Lung Cancer)2023-09-20T12:45:20-05:00April 28th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research, Small Cell Lung Cancer|

Author: Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program, GO2 for Lung Cancer People with lung cancer receiving treatment may encounter acquired drug resistance—a reduction in treatment effectiveness over time. Tagrisso (osimertinib) is currently a frontline treatment for people diagnosed with non-small cell lung cancer (NSCLC) with an EGFR mutation. However, acquired resistance to Tagrisso (osimertinib) is a problem for a significant group of EGFR+ patients and can even cause transformation from non-small cell lung cancer to small cell lung [...]

1

Lung Cancer Living Room: Living with Small Cell Lung Cancer

Bradley Newton2022-07-25T12:45:51-05:00February 3rd, 2022|Living Room|

Learn about lung cancer and its treatments through in-depth conversations with healthcare experts, people with lung cancer, and caregivers through our signature Lung Cancer Living Room monthly speaker series. Join from the comfort and safety of your home via YouTube Live.

Comments Off

Search results for "Small cell lung cancer".